Head and Neck

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(GSK) 221530 / JADEA Randomized, Double-blind, Placebo-controlled Phase 3 Study to evaluate Dostarlimab as Sequential Therapy after Chemoradiation in Participants with Locally Advanced Unresected Head and Neck Squamous Cell CarcinomaDr Baskoro (Adi) KartoloOpen to recruitmentNCT06256588
(JCC) SHINE / HNSBRTA Phase 2 Study of SBRT for Squamous Cell Carcinoma of the Head and NeckDr Justin LeeOpen to recruitmentNCT04435938
Download PDF